Whitehawk Therapeutics (WHWK) Net Equity Issued and Repurchased (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Net Equity Issued and Repurchased of $56,000 for Q2 2026, compared with $5,000 a year earlier.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Whitehawk Therapeutics' Net Equity Issued and Repurchased came in at $79,000, up 1.3% year-over-year; for FY2025, it came in at $49,000, down 66.4% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -65.3% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $146,000 in FY2024 (-64.2%), $408,000 in FY2023 (+1.7%), $401,000 in FY2022 (-99.7%) and $155 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q2 2024.
- The high point for year-over-year Net Equity Issued and Repurchased in five years was Q1 2022 (growth of 247.2%); the low point was Q3 2022 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Whitehawk Therapeutics | 311.65 Mn | 311.65 Mn | - | 56,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56,000.00 |
| Dec 31, 2025 | 23,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Jun 30, 2023 | 286,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 136,000.00 |
| Mar 31, 2022 | 244,000.00 |
| Sep 30, 2021 | 155.00 Mn |
| Jun 30, 2021 | -70,279.00 |
| Mar 31, 2021 | 70,279.00 |
| Sep 30, 2018 | 6.62 Mn |
| Jun 30, 2018 | 44.98 Mn |
| Mar 31, 2018 | 21,992.00 |
| Dec 31, 2017 | 2.00 |
API Access
Whitehawk Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=WHWK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "WHWK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=WHWK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();